Ablynx N.V.
Ablynx is a biopharmaceutical company that engages in the discovery and development of Nanobodies for the small-molecule drug applications.
Business Model:
Revenue: $108M
Employees: 201-500
Industries / Tags:
Detailed Ablynx N.V. Information
Ablynx N.V. was acquired by
Sanofi.
The acquisition happend on 2018-01-29.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Technologiepark 21
City: Ghent
State: east flanders
Zip: 9052
Country: BE
Financial Info
Stage:
post ipo equity
Raised Last:
$230M
Raised Total:$344M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Ablynx is a biopharmaceutical company that engages in the discovery and development of Nanobodies for the small-molecule drug applications.
Contact Phone:
Contact Email:
Ablynx N.V. went public on 11/16/2007 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/16/2007
Ticker Symbol:
ABLX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2014 | Grant | 1 | $2.8M |
Gimv Gimv |
4/2004 | Series B | 6 | $30M |
Alta Partners Sofinnova Partners Gimv Gilde Healthcare Biotech Fund Flanders Abingworth Alta Partners |
9/2002 | Series A | 3 | $4.9M |
Sofinnova Partners Gimv Gilde Healthcare |
8/2006 | Series C | 8 | $50M |
KBC Abingworth Biotech Fund Flanders Gilde Healthcare Sofinnova Partners Gimv KBC SR One Alta Partners KBC Abingworth Biotech Fund Flanders Gilde Healthcare Sofinnova Partners Gimv KBC |
11/2009 | Grant | $1.6M | 3/2010 | Secondary Offering | $78.1M | 2/2013 | Private Placement | $41.2M | 2/2013 | Post-IPO Equity | $41.2M | 7/2014 | Private Placement | $57M | 6/2016 | Post-IPO Equity | $82.8M | 10/2017 | Post-IPO Equity | $230M | 6/2014 | Post-IPO Equity | $0 |
Jefferies KBC Securities Kempen &a; Co Jefferies KBC Securities Kempen &a; Co |
6/2014 | Post-IPO Equity | 3 | $57.1M |
Jefferies KBC Securities Kempen &a; Co Jefferies KBC Securities Kempen &a; Co |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
